IP Verse

Crispr Therapeutics Ag opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Crispr Therapeutics Ag

Patent Number:
EP3603679
Title:
Rna-Guideded Transcriptional Regulation
Applicant:
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Opposition Date:
Aug 11, 2022
Patent Number:
EP3733847
Title:
Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof
Applicant:
TOOLGEN INCORPORATED
Opposition Date:
Jun 2, 2022
Patent Number:
EP3327127
Title:
Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Sequence Manipulation And Therapeutic Applications
Applicant:
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Opposition Date:
Apr 7, 2021
Patent Number:
EP3011031
Title:
Delivery And Use Of The Crispr-Cas Systems, Vectors And Compositions For Hepatic Targeting And Therapy
Applicant:
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Opposition Date:
Nov 13, 2020
Patent Number:
EP3252160
Title:
Crispr-Cas Component Systems, Methods And Compositions For Sequence Manipulation
Applicant:
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Opposition Date:
Oct 29, 2020
Patent Number:
EP3144390
Title:
Engineering Of Systems, Methods And Optimized Guide Compositions For Sequence Manipulation
Applicant:
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Opposition Date:
Mar 19, 2020
Patent Number:
EP3064585
Title:
Engineering And Optimization Of Improved Systems, Methods And Enzyme Compositions For Sequence Manipulation
Applicant:
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Opposition Date:
Feb 10, 2020
Patent Number:
EP3494997
Title:
Inducible Dna Binding Proteins And Genome Perturbation Tools And Applications Thereof
Applicant:
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Opposition Date:
Feb 10, 2020
Patent Number:
EP2940140
Title:
Engineering Of Systems, Methods And Optimized Guide Compositions For Sequence Manipulation
Applicant:
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Opposition Date:
Nov 5, 2019
Patent Number:
EP2931892
Title:
Methods, Models, Systems, And Apparatus For Identifying Target Sequences For Cas Enzymes Or Crispr-Cas Systems For Target Sequences And Conveying Results Thereof
Applicant:
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Opposition Date:
Feb 28, 2019

Competitors of Crispr Therapeutics Ag

PRESIDENT AND FELLOWS OF HARVARD COLLEGE

MASSACHUSETTS INSTITUTE OF TECHNOLOGY

THE BROAD INSTITUTE, INC.

Want to track Crispr Therapeutics Ag?

Feel free to send us a message here and we will get back to you